870 related articles for article (PubMed ID: 25500159)
21. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
[TBL] [Abstract][Full Text] [Related]
22. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z
Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
Gál I; Lakos G; Zeher M
Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
[TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
25. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.
Min JH; Kim HJ; Kim BJ; Lee KW; Sunwoo IN; Kim SM; Kim BJ; Kim SH; Park MS; Waters P; Vincent A; Sung JJ; Lee KH
Mult Scler; 2009 Sep; 15(9):1069-76. PubMed ID: 19625331
[TBL] [Abstract][Full Text] [Related]
26. Comparisons of presentations and outcomes of neuromyelitis optica patients with and without Sjögren's syndrome.
Zhong YH; Zhong ZG; Zhou Z; Ma ZY; Qiu MY; Peng FH; Zhang WX
Neurol Sci; 2017 Feb; 38(2):271-277. PubMed ID: 27817092
[TBL] [Abstract][Full Text] [Related]
27. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
Jarius S; Aboul-Enein F; Waters P; Kuenz B; Hauser A; Berger T; Lang W; Reindl M; Vincent A; Kristoferitsch W
Brain; 2008 Nov; 131(Pt 11):3072-80. PubMed ID: 18945724
[TBL] [Abstract][Full Text] [Related]
28. [Clinical concept, etiology and pathology of neuromyelitis optica].
Kurosawa K; Fujihara K
Nihon Rinsho; 2014 Nov; 72(11):1897-902. PubMed ID: 25518368
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders.
Jarius S; Franciotta D; Bergamaschi R; Wildemann B; Wandinger KP
Clin Chem Lab Med; 2010 May; 48(5):659-63. PubMed ID: 20184532
[TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.
Jarius S; Franciotta D; Paul F; Ruprecht K; Bergamaschi R; Rommer PS; Reuss R; Probst C; Kristoferitsch W; Wandinger KP; Wildemann B
J Neuroinflammation; 2010 Sep; 7():52. PubMed ID: 20825655
[TBL] [Abstract][Full Text] [Related]
31. Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis.
Wu L; Huang D; Yang Y; Wu W
Eur Neurol; 2014; 72(1-2):103-8. PubMed ID: 24993096
[TBL] [Abstract][Full Text] [Related]
32. Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.
Marignier R; Bernard-Valnet R; Giraudon P; Collongues N; Papeix C; Zéphir H; Cavillon G; Rogemond V; Casey R; Frangoulis B; De Sèze J; Vukusic S; Honnorat J; Confavreux C;
Neurology; 2013 Jun; 80(24):2194-200. PubMed ID: 23658379
[TBL] [Abstract][Full Text] [Related]
33. Anti-aquaporin-4 antibody positivity in neuromyelitis optica is associated with lesion activity.
Liu Y; Han Y; Duan Y; Huang J; Ren Z; Butzkueven H; Li K
Eur Neurol; 2013; 70(1-2):113-6. PubMed ID: 23860467
[TBL] [Abstract][Full Text] [Related]
34. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].
Yoshida M
Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307
[TBL] [Abstract][Full Text] [Related]
35. Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.
Chang X; Huang W; Wang L; ZhangBao J; Zhou L; Lu C; Wang M; Yu J; Li H; Li Y; Zhao C; Lu J; Quan C
Front Immunol; 2021; 12():647618. PubMed ID: 33796113
[No Abstract] [Full Text] [Related]
36. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.
Jarius S; Probst C; Borowski K; Franciotta D; Wildemann B; Stoecker W; Wandinger KP
J Neurol Sci; 2010 Apr; 291(1-2):52-6. PubMed ID: 20117794
[TBL] [Abstract][Full Text] [Related]
37. Multiple Autoantibodies and Neuromyelitis Optica Spectrum Disorders.
Chen C; Xiaobo S; Yuge W; Yaqing S; Ling F; Lisheng P; Zhengqi L; Wei Q
Neuroimmunomodulation; 2016; 23(3):151-156. PubMed ID: 27603214
[TBL] [Abstract][Full Text] [Related]
38. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
[TBL] [Abstract][Full Text] [Related]
39. [The role of aquaporin 4 antibody in the injury of retinal microstructure in neuromyelitis optica spectrum disorders].
Wang ZW; Wang QQ; Diao DW; Guo QF; Qi XK
Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):435-439. PubMed ID: 29925129
[No Abstract] [Full Text] [Related]
40. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J
JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
